Free tool
Stocks listed on B3 São Paulo
We cover 31 companies listed on B3 São Paulo. The median market value in the group is $1.08B. Across the group, the median move over the past trading day is −0.72%. 42% of the 24 with a 200-day average trade above it. Price change over the past year runs from −17.9% to +63.3% across the middle 80 percent of the group, with a median of +11.8%.
Other lists in this group
Table
31 of 2,037 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| LILY34.SA | Eli Lilly and Company | $1.10T | Mega cap | +59.83% |
| JNJB34.SA | Johnson & Johnson | $658.09B | Mega cap | +47.82% |
| ABBV34.SA | AbbVie Inc. | $467.00B | Mega cap | +21.88% |
| N1VS34.SA | Novartis AG | $301.83B | Mega cap | +20.04% |
| A1ZN34.SA | AstraZeneca PLC | $258.63B | Mega cap | +0.13% |
| N1VO34.SA | Novo Nordisk A/S | $208.90B | Mega cap | −17.86% |
| E2XE34.SA | Exelixis, Inc. | $6.61B | Mid cap | +23.92% |
| RADL3.SA | Raia Drogasil S.A. | $6.56B | Mid cap | +7.42% |
| T1FX34.SA | Teleflex Incorporated | $6.00B | Mid cap | +0.29% |
| HYPE3.SA | Hypera S.A. | $2.98B | Mid cap | −4.69% |
| CLOV34.SA | Clover Health Investments, Corp. | $2.15B | Mid cap | +45.23% |
| S1RP34.SA | Sarepta Therapeutics, Inc. | $1.98B | Small cap | −12.20% |
| FLRY3.SA | Fleury S.A. | $1.97B | Small cap | +37.82% |
| A2RR34.SA | Arrowhead Pharmaceuticals, Inc. | $1.58B | Small cap | +298.89% |
| T2DH34.SA | Teladoc Health, Inc. | $1.13B | Small cap | −24.67% |
| J2AZ34.SA | Jazz Pharmaceuticals plc | $1.08B | Small cap | +35.66% |
| B2RK34.SA | Bruker Corporation | $906.52M | Small cap | +63.27% |
| D2OC34.SA | Doximity, Inc. | $733.94M | Small cap | −65.76% |
| C2RS34.SA | CRISPR Therapeutics AG | $704.10M | Small cap | +0.85% |
| DASA3.SA | Diagnósticos da América S.A. | $633.57M | Small cap | +93.33% |
| PGMN3.SA | Empreendimentos Pague Menos S.A. | $481.69M | Small cap | −1.57% |
| BLAU3.SA | Blau Farmacêutica S.A. | $406.91M | Small cap | −2.28% |
| PNVL3.SA | Dimed S.A. Distribuidora de Medicamentos | $350.76M | Small cap | +20.56% |
| P2OD34.SA | Insulet Corporation | $332.45M | Small cap | −26.20% |
| MATD3.SA | Hospital Mater Dei S.A. | $321.33M | Small cap | +11.78% |
| OFSA3.SA | Ouro Fino Saúde Animal Participações S.A. | $256.27M | Small cap | +18.69% |
| R2AR34.SA | Ultragenyx Pharmaceutical Inc. | $255.25M | Small cap | +11.74% |
| N2VC34.SA | NovoCure Limited | $202.19M | Small cap | +67.42% |
| PFRM3.SA | Profarma Distribuidora de Produtos Farmacêuticos S.A. | $177.65M | Small cap | −1.92% |
| BIOM3.SA | Biomm S.A. | $171.18M | Small cap | +0.63% |
| T2ND34.SA | Tandem Diabetes Care, Inc. | $110.42M | Small cap | +41.78% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.